Manufacturing

Mar 05, 2018
By BioPharm International Editors
JLL, a real estate and investment management firm, recently released a new report on three trends shaping labs for the future of life sciences R&D.
Mar 02, 2018
By BioPharm International Editors
Catalent completes $4.6 million expansion at Singapore clinical supply facility and marks 20 years in the region.
Mar 01, 2018
BioPharm International
Biologic new molecular entities (NMEs) accounted for 26% of total NME approvals in 2017.
Mar 01, 2018
BioPharm International
Spectroscopic tools present an alternative method for reliable at-line process monitoring and control.
Mar 01, 2018
BioPharm International
Alan Kennedy, executive director of TEAM UP, shared perspectives on Poseidon and ocean transport.
Mar 01, 2018
BioPharm International
Lower costs, fewer opportunities for temperature excursions, and a smaller carbon footprint are making ocean transport more attractive for pharmaceuticals. Poseidon, a new collaborative pharma initiative, seeks to leverage benefits.
Mar 01, 2018
BioPharm International
Modeling at various stages of the data analytics continuum aids scale comparison of a bioreactor.
Feb 23, 2018
By BioPharm International Editors
The company is voluntarily recalling three lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial and one lot of Labetalol Hydrochloride Injection, USP, Novaplus because of the potential of cracked glass at the rim of the vials.
Feb 23, 2018
By BioPharm International Editors
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
Feb 22, 2018
By BioPharm International Editors
The agreement follows the recent opening of WuXi STA's oligonucleotide R&D labs in China and the US.
native1_300x100
lorem ipsum